Skeletal and Uterotrophic Effects of Endoxifen in Female Rats

Endoxifen, the primary active metabolite of tamoxifen, is currently being investigated as a novel endocrine therapy for the treatment of breast cancer. Tamoxifen is a selective estrogen receptor modulator that elicits potent anti–breast cancer effects. However, long-term use of tamoxifen also induce...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrinology
Hauptverfasser: Gingery, Anne, Iwaniec, Urszula T., Subramaniam, Malayannan, Turner, Russell T., Pitel, Kevin S., McGovern, Renee M., Reid, Joel M., Marler, Ronald J., Ingle, James N., Goetz, Matthew P., Hawse, John R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Endocrine Society 2017
Schlagworte:
Research Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5659691/
https://ncbi.nlm.nih.gov/pubmed/28977607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2016-1871
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge